SWOG S1937

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary

Status:

New, Open

A Phase III Randomized Trial of Eribulin (NSC #707389) with or Without Gemcitabine Versus Standard of Care (Physician’s Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy

Eligible for screening study DCP 001

NCT#04579224